Skip to main content
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline.
Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert Experience.
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.
Revolutionizing OGTT: Unlocking the Real-time Insights and Expanded Data of Continuous Glucose Monitoring (CGM).
Disordered electron transfer: New forms of defective steroidogenesis and mitochondriopathy.
Development of 24-hour rhythms in cortisol secretion across infancy: a systematic review and meta-analysis of individual participant data.
Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women.
Burosumab Versus Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Sub-group Analysis by Dose Level.
Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.
Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia.